Medical versus medical and surgical treatment for brucella endocarditis
- PMID: 23102495
- PMCID: PMC3508082
- DOI: 10.1016/j.athoracsur.2012.07.006
Medical versus medical and surgical treatment for brucella endocarditis
Abstract
This review was undertaken to determine the role of surgery in the treatment of brucella endocarditis. All English and French articles reporting brucella endocarditis (1966 to 2011) in PubMed, Google, and Scopus were reviewed. In all, 308 cases were identified, and linear and logistic regression was performed. Surgery improved outcomes by decreasing mortality from 32.7% in the medical treatment only group to 6.7% in the combined surgical and medical treatment group (p<0.001). This association was still significant while controlling for other contributing factors. In the absence of a controlled trial, we recommend the utmost vigilance and consideration of surgical management in treating such patients.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
References
-
- Valliattu J, Shuhaiber H, Kiwan Y, Araj G, Chugh T. Brucella endocarditis. Report of one case and review of the literature. J Cardiovasc Surg. 1989;30(5):782–5. - PubMed
-
- Ferreira P, Gama P, Correia J, et al. Brucella endocarditis--case report and literature review. Rev Port Cardiol. 2008;27(10):1309–15. - PubMed
-
- Memish Z, Mah MW, Al Mahmoud S, Al Shaalan M, Khan MY. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J Infect. 2000;40(1):59–63. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
